FDA Zaps Tongue Nerve Stimulators into Moderate Regulation Category
Published Date: 12/19/2025
Rule
Summary
The FDA is officially classifying the electrical tongue nerve stimulator, a device that helps people with movement problems, as a Class II device with special safety rules. This change makes it easier and faster for patients to get this innovative treatment by reducing some regulatory hurdles. The new classification is effective December 19, 2025, and could speed up device availability without extra costs for users.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
Class II ruling speeds patient access
The FDA classified the electrical tongue nerve stimulator as a Class II device with special controls, which the agency says will enhance patients' access and reduce regulatory burdens. The final order is effective December 19, 2025, and FDA states this classification can make it easier and faster for patients to get this treatment.
Creates predicate for future devices
Because FDA classified this device via the De Novo process, the electrical tongue nerve stimulator can serve as a predicate device. Future device sponsors can use the less-burdensome 510(k) process instead of a De Novo request or premarket approval, lowering regulatory hurdles for companies making similar devices.
Manufacturers must meet special controls
To be classified as Class II, manufacturers must meet special controls including biocompatibility testing for patient-contacting components; electromagnetic, battery, electrical, mechanical, and thermal safety testing; non-clinical performance testing of stimulation parameters; software verification/validation and cybersecurity assessment; and specific labeling (technical summary, instructions, cleaning, storage, charging, disposal).
Device is prescription-only
The FDA states the electrical tongue nerve stimulator is a prescription device. That means the device is available only with a prescription and is exempt from layperson 'adequate directions for use' requirements under specified statutory provisions.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10321 — Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) Manufactured by Moderna TX Inc.
The FDA is holding a public meeting on June 18, 2026, to talk about the safety and effectiveness of MFLUSIVA, a new flu vaccine made by Moderna. Anyone can watch online and share their thoughts before June 17. This is a big deal for people who get flu shots and could affect how this vaccine is used and approved.
2026-10295 — M11 Clinical Electronic Structured Harmonised Protocol (CeSHarP); International Council for Harmonisation; Guidance for Industry; Availability
The FDA just released a new, easy-to-use digital guide called M11 CeSHarP to help everyone involved in clinical trials share and review study plans faster and clearer. This affects drug companies, researchers, and regulators worldwide by setting a global standard for how trial info is written and shared electronically. The new rules kick in now, aiming to save time and reduce confusion, with no direct cost but big efficiency gains.
2026-10277 — Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
The FDA just released new draft guides to help drug makers design studies proving their generic drugs work like the originals. If you’re in the drug business, now’s your chance to share feedback by July 21, 2026, before these guides become final. These updates aim to speed up drug approvals, potentially saving time and money for companies and patients alike!
2026-10284 — Protein Efficiency Ratio Rat Bioassay Studies To Demonstrate That a New Infant Formula Supports the Quality Factor of Sufficient Biological Quality of Protein; Guidance for Industry; Availability
The FDA just released new guidance to help baby formula makers prove their products have good-quality protein using special rat studies. This update affects formula manufacturers and labs, making it easier and clearer to show their formulas meet nutrition standards. The guidance is effective now, helping companies avoid costly mistakes and speed up getting new formulas to market.
2026-10268 — Notice of Decision Not To Designate Hepatitis Delta Virus Diseases as an Addition to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act
The FDA decided not to add Hepatitis Delta Virus (HDV) to the list of tropical diseases because it doesn’t fully meet the rules about market size and who it affects. This means drug makers won’t get special priority review vouchers for HDV treatments right now. People working on HDV drugs should keep an eye out for future updates but won’t see changes or new incentives immediately.
2026-10190 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Patent Term Restoration; Due Diligence Petitions; Filing, Format, and Content of Petitions
The FDA is updating how companies ask for extra patent time when their new drugs or devices take a while to get approved. This affects drug and medical device makers who want to protect their inventions longer. Comments on these changes are open until June 22, 2026, and the update aims to keep the process clear without adding extra costs or delays.
Previous / Next Documents
Previous: 2025-23412 — Safety Zone; Fireworks Display, Ohio River Mile Marker 73 to 74, Wellsburg, WV
The Coast Guard is setting up a temporary safety zone on the Ohio River near Wellsburg, WV, from 11 p.m. on December 31, 2025, to 1 a.m. on January 1, 2026, to keep everyone safe during the New Year's Eve fireworks show. Boats and people can’t enter this area unless they get special permission. This quick action helps prevent accidents from fireworks and keeps the river safe without causing delays or costs.
Next: 2025-23414 — Falsification, Reproduction, Alteration, Omission, or Incorrect Statements
The FAA fixed a rule mix-up that accidentally deleted whole sections instead of just small parts about lying or messing with official aviation documents. This fix puts those sections back where they belong, affecting airlines, flight schools, and commercial space operators. The corrected rules take effect December 19, 2025, so everyone should update their records to avoid trouble.